According to FutureWise analysis the market for GI stool testing in 2023 is US$ 1.03 billion, and is expected to reach US$ 1.6 billion by 2031 at a CAGR of 7.1%.

GI stool testing is a diagnostic process that involves analyzing fecal samples to detect intestinal infections or diseases. This testing is crucial for identifying various gastrointestinal (GI) disorders, including bowel inflammation, malabsorption, and cancer. The rising incidence of GI diseases, driven by factors such as increased consumption of junk food, fast-paced lifestyles, and an aging population, is fueling growth in the GI stool testing market. As more individuals face gastrointestinal infections, both public and private sectors are anticipated to ramp up investments in healthcare, contributing further to market expansion.

Numerous studies have established a link between gut health and overall well-being, highlighting the significant role that gut microbiota plays in mediating the effects of nutrition and other influential factors on health, including digestive, immune, metabolic, and neuroendocrine processes. Properly assessing GI health is essential for practitioners aiming to uncover the root causes of chronic illnesses.

One innovative method used in this field is the SDNA test, often referred to as the FIT-DNA test. This test detects traces of DNA (genetic material) shed by polyps or colon cancers in the stool, providing a non-invasive alternative to traditional blood detection methods. The Cologuard test is one of the most recognized stool tests for this type of screening, as it can identify both blood in stool samples and ten other indicators associated with colon cancer, making it a valuable tool in early detection.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=3640%20&type=requestsample

Gastrointestinal (GI) Stool Testing Market Segmentation:

By Product Type

• Reagents
• Instruments

By Application

• Colorectal Cancer
• Diarrhea
• GI Tract Infections
• Others (Poor Absorption Problems, Parasites)

By Test

• Microscopy Test
• Ova & Parasites Test
• Culture Test
• Bacteria Test
• Occult Blood test
  • Guaiac FOB Stool Test
  • Immuno-FOB agglutination test
  • Lateral Flow Immuno-FOB Test
  • Immuno-FOB ELISA Test
• Stool Biomarkers Tests
  • Cologuard
  • M2-PK Stool Test
• Others

By End User

• Hospitals
• Diagnostic Centres and Laboratories
• Academic Institutions
• Research Centres & Organizations
• Home

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Gastrointestinal (GI) Stool Testing Market:

• Abbott Laboratories 
• Alere 
• Beckman Coulter 
• BioMrieux
• Bio-Rad Laboratories 
• Cenogenics Corporation 
• DiaSorin 
• Meridian Bioscience
• Quest Diagnostics Incorporated
• Siemens Healthcare 

Ask For Discount: https://www.futurewiseresearch.com/checkout.aspx?ReportId=3640&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Gastrointestinal (GI) Stool Testing Market By Product Type, By Application, By Test, By End User and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa                                                                                                
   Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com